Real-World Pathologic Complete Response Rates with Neoadjuvant Pembrolizumab in Stage II–III Triple-Negative Breast Cancer: Impact of Ki-67 Proliferation Index

Articles > Article · 2025

Authors: GÖKHAN ŞAHİN, OĞUZCAN ÖZKAN, Caner ACAR, HAYDAR ÇAĞATAY YÜKSEL, Sercan ÖN, HASAN ÇAĞRI YILDIRIM, Burcu ÇAKAR, Erhan GÖKMEN

UHOD - ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, Journal Indexed in SCI Expanded, International, 2025, pp 178-185